Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 2D Speckle-tracking Echocardiography in Diagnosis Chemotherapy-induced Cardiomyopathy in Breast Cancer Patients With High Cardiovascular Risk Factors

NCT04547465 is registered in ClinicalTrials.gov with Gia Dinh People Hospital as lead sponsor.

NCT NCT04547465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 2D Speckle-tracking Echocardiography in Diagnosis Chemotherapy-induced Cardiomyopathy in Breast Cancer Patients With High Cardiovascular Risk Factors
Lead sponsor
Gia Dinh People Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2020
Completion date
December 30, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiomyopathy due to drug, cardiovascular risk factor